GILD241108C65000
- 0.00
- 0.000.00%
Gilead Sciences Newsroom
Tuesday Market Closed Up, with Presidency in Sight | Wall Street Today
Arcus Says Gilead-partnered Cancer Therapy Cut Death Risk by 36%
We Want YOU to Submit Questions for Election Night
Market Climbs for Election Day Excitement | Live Stock
Arcellx Issues Updates on Anito-cel Clinical Trials
Gilead's Kite To Highlight CAR T-Cell Therapy Portfolio At ASH 2024, Including Survival Outcomes In Both Clinical Trials And The Real-World
Express News | Kite to Highlight Industry-Leading Car T-Cell Therapy Portfolio at Ash 2024, Including Positive Survival Outcomes in Both Clinical Trials and the Real-World
Monday Market Moves Sideways, Election and FOMC in Sight | Wall Street Today
Gilead Science to Report Q3 Earnings: What's in the Cards?
Monday Market Mixed Before Crazy, Pivotal Week | Live Stock
Gilead Sciences Hits 8-1/2-year High
Jefferies Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $105
Jefferies Remains a Buy on Gilead Sciences (GILD)
These Stocks Are Moving the Most Today: Nvidia, Apple, Sherwin-Williams, DJT, Talen Energy, Constellation Energy, and More
US Equity Investors to Look Out for Presidential Election Results, Fed Rate Cut, Quarterly Earnings This Week
Nvidia, Apple, Sherwin-Williams, DJT, Viking Therapeutics, Talen Energy, and More Stock Market Movers
Earnings Week Ahead: O, PLTR, QCOM, SQ, AMC, PARA, LCID, RIVN, WBD, and More
Express News | Gilead : Jefferies Raises Target Price to $105 From $95
Super Micro, Ferrari, Marriott, Airbnb, Novo Nordisk, and More Stocks to Watch This Week
Weekly Buzz: Magnificent Mix of Market Reactions